drugset / Trial / NCT03313297

Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)

NCT03313297

Phase 2 Completed 28 enrolled University of Leeds
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aims to investigate effects of inhibiting glucocorticoid activation on skin function and wound healing in patients with type 2 diabetes. Half of patients will be given a drug to inhibit glucocorticoid activation and the other half will be given a placebo.

Timeline

Start
2018-04-10
Primary completion
2019-02-27
Completion
2019-03-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator AZD4017 Small molecule 400 mg Oral